Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease
Studying Kawasaki disease
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Children's Hospital of Fudan University
- Principal Investigator
- Fang Liu, MD.Children's Hospital of Fudan University
- Intervention
- IVIG(drug)
- Enrollment
- 3208 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2025
Study locations (30)
- Bengbu First People's Hopital, Bengbu, Anhui, China
- Anhui Children's Hospital, Hefei, Anhui, China
- Children's Hospital, Capital Institute of Pediatrics, Beijing, Beijing Municipality, China
- Children's Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
- Xiamen Children's Hospital, Xiamen, Fujian, China
- Lanzhou University Second Hospital, Lanzhou, Gansu, China
- Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
- Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
- Shenzhen Children's Hospital, Shenzhen, Guangdong, China
- Liuzhou Maternity and Children Healthcare Hospital, Liuchow, Guangxi, China
- Kaifeng Children's Hospital, Kaifeng, Henan, China
- Henan Children's Hospital, Zhengzhou, Henan, China
- the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Taihe Hospital Affiliated Hospital of Hubei University of Medicine, Shiyan, Hubei, China
- +15 more locations on ClinicalTrials.gov
Collaborators
Jiangxi Province Children's Hospital · First People's Hospital of Hangzhou · Shengjing Hospital · The First Hospital of Jilin University · Chengdu Women's and Children's Central Hospital · Children's Hospital of Chongqing Medical University · Inner Mongolia People's Hospital · Sichuan Provincial People's Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Third Affiliated Hospital of Zhengzhou University · Children's Hospital of Soochow University · Yuying Children's Hospital of Wenzhou Medical University · Beijing Children's Hospital · Qilu Hospital of Shandong University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04078568 on ClinicalTrials.govOther trials for Kawasaki disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05643651Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGNANCT07291245Kawasaki MATCH TrialUniversity of California, San Diego
- ENROLLING BY INVITATIONNCT06641843Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular DiseaseWest China Second University Hospital
- RECRUITINGPHASE4NCT06978439Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki DiseaseChildren's Hospital of Fudan University
- RECRUITINGPHASE3NCT04656184A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG TreatmentAssistance Publique - Hôpitaux de Paris
- ENROLLING BY INVITATIONNCT06641817The Value of Cardiovascular Imaging in Kawasaki DiseaseWest China Second University Hospital
- RECRUITINGNCT06993636Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 YearsChildren's Hospital of Fudan University
- RECRUITINGNCT06305611European and North Indian Cohort of KaWasaki dIseaseMeyer Children's Hospital IRCCS